← Evidence map

ReviewOncology letters2020

BRM270 targets cancer stem cells and augments chemo-sensitivity in cancer.

Nisansala Chandimali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 32831922